A 37 year old Rumanian man developed thrombosis in ’92 and ’93. As this was not treated correctly, his first wounds developed in ’95. In ‘02 his CVI was at stage II. In ‘06 his CVI was at stage III and he had developed a chronic ulcus cruris venosum. In 2009 the patient was presented again and then it became apparent, that after three years the wounds had had little progress.

From then on the wounds were treated with the honey-based L-Mesitran. During the treatment no systemic antibiotics were administered. The wounds improved very slightly and after two years a joined decision was made that the patient was no longer followed up with pictures etc. because it became apparent that this patient had underlying pathology that prevented full wound healing. The only option for full healing might be a surgical intervention.

However, the main advantage the honey based products had for this CVI patient was, that during the treatment no systemic antibiotics were needed to combat and prevent infection. Thus the honey products contributed to the reduction of the use of antibiotics and aiding in preventing antibiotic resistance.

You can click here to read the complete story.

Please do not hesitate to contact us, should you have any questions regarding the presented case study.The case study is also available in Dutch (on demand)

June 20, 2011